Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.5299 USD
-2.91%
Market Closed
Updated:
May 13, 2024
Atara Biotherapeutics Inc
Other Non-Cash Items
|
Atara Biotherapeutics Inc
Other Non-Cash Items Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Other Non-Cash Items
$63m
|
CAGR 3-Years
5%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$9.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
32%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
8%
|
CAGR 10-Years
23%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$1.8B
|
CAGR 3-Years
157%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$538.6m
|
CAGR 3-Years
37%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-5%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
110%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Atara Biotherapeutics Inc's Other Non-Cash Items?
Other Non-Cash Items
63m
USD
63m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Other Non-Cash Items amounts to 63m USD.
What is Atara Biotherapeutics Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
14%
14%
Over the last year, the Other Non-Cash Items growth was 360%. The average annual Other Non-Cash Items growth rates for Atara Biotherapeutics Inc have been 5% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
